Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Scienion: Market-driven chips

The biochip market is dominated by Affymetrix Inc., but Scienion AG believes it has technology that doesn't step on AFFX's toes. The company is selling into the lucrative microbial research market niche, which it hopes could make it profitable next year and obviate the need to raise more venture money.

Scienion is a

Read the full 525 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE